Donor Immunization Against Human Leukocyte Class II Antigens is a Risk Factor for Graft-versus-Host Disease.
Delbos F, Barhoumi W, Cabanne L, Beckerich F, Robin C, Redjoul R, Astati S, Toma A, Pautas C, Ansart-Pirenne H, Cordonnier C, Bierling P, Maury S.
Delbos F, et al. Among authors: ansart pirenne h.
Biol Blood Marrow Transplant. 2016 Feb;22(2):292-299. doi: 10.1016/j.bbmt.2015.09.027. Epub 2015 Nov 11.
Biol Blood Marrow Transplant. 2016.
PMID: 26453972
Free article.